The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for clinical laboratories and commercial manufacturers that are developing or have developed diagnostic tests for SARS-CoV-2. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2.
On March 16, 2020, the FDA issued updated policy on COVID-19 Diagnostics: Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency.
Registration is not necessary.
To ensure you are connected, please dial in 15 minutes prior to the start of the call.
U.S. Callers Dial:
International Callers Dial:
To view the slide presentation during the webinar:
https://www.mymeetings.com/nc/join.php?i=RWXW1175579&p=6110103&t=cExternal Link Disclaimer
Following the webinar, a transcript, recoding, and slides will be posted below.